The Association Between Hypertriglyceridemic-Waist Phenotype and Chronic Kidney Disease in Patients with Type 2 Diabetes: A Cross-Sectional METAL Study

References

• Bikbov B, Purcell CA, Levey AS; Collaboration GBDCKD. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–733. doi:10.1016/S0140-6736(20)30045-3
   PubMed Web of Science ®Google Scholar
• Miyata Y, Obata Y, Mochizuki Y, et al. Periodontal disease in patients receiving dialysis. Int J Mol Sci. 2019;20(15):3805. doi:10.3390/ijms20153805
   PubMed Web of Science ®Google Scholar
• Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015;3(7):514–525. doi:10.1016/S2213-8587(15)00040-6
   PubMed Web of Science ®Google Scholar
• Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17(7):2034–2047. doi:10.1681/ASN.2005101085
   PubMed Web of Science ®Google Scholar
• Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–1982. doi:10.1016/S0140-6736(14)61601-9
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Zoccali C, Ikizler TA. Obesity in CKD–what should nephrologists know? J Am Soc Nephrol. 2013;24(11):1727–1736. doi:10.1681/ASN.2013040330
   PubMed Web of Science ®Google Scholar
• Yang C, Wang H, Zhao X, et al. CKD in china: evolving spectrum and public health implications. Am J Kidney Dis. 2020;76(2):258–264. doi:10.1053/j.ajkd.2019.05.032
   PubMed Web of Science ®Google Scholar
• Santos A, Magro DO, Evangelista-Poderoso R, Saad MJA. Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications. Diabetol Metab Syndr. 2021;13(1):23. doi:10.1186/s13098-021-00639-2
   PubMed Web of Science ®Google Scholar
• Ali I. Syndemics at play: chronic kidney disease, diabetes and COVID-19 in Pakistan. Ann Med. 2021;53(1):581–586. doi:10.1080/07853890.2021.1910335
   PubMed Web of Science ®Google Scholar
• Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive Type 2 diabetes management algorithm - 2018 executive summary. Endocr Pract. 2018;24(1):91–120. doi:10.4158/CS-2017-0153
   PubMed Web of Science ®Google Scholar
• Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102(2):179–184. doi:10.1161/01.CIR.102.2.179
   PubMed Web of Science ®Google Scholar
• Madero M, Katz R, Murphy R, et al. Comparison between different measures of body fat with kidney function decline and incident CKD. Clin J Am Soc Nephrol. 2017;12(6):893–903. doi:10.2215/CJN.07010716
   PubMed Web of Science ®Google Scholar
• Zhang YB, Sheng LT, Wei W, et al. Association of blood lipid profile with incident chronic kidney disease: a Mendelian randomization study. Atherosclerosis. 2020;300:19–25. doi:10.1016/j.atherosclerosis.2020.03.020
   PubMed Web of Science ®Google Scholar
• Sam S, Haffner S, Davidson MH, et al. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care. 2009;32(10):1916–1920. doi:10.2337/dc09-0412
   PubMed Web of Science ®Google Scholar
• Lemieux I, Poirier P, Bergeron J, et al. Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? Can J Cardiol. 2007;23(Suppl B):23B–31B. doi:10.1016/S0828-282X(07)71007-3
   PubMed Web of Science ®Google Scholar
• Janghorbani M, Salamat MR, Aminorroaya A, Amini M. Utility of the visceral adiposity index and hypertriglyceridemic waist phenotype for predicting incident hypertension. Endocrinol Metab. 2017;32(2):221–229. doi:10.3803/EnM.2017.32.2.221
   Web of Science ®Google Scholar
• Gomez-Huelgas R, Bernal-Lopez MR, Villalobos A, et al. Hypertriglyceridemic waist: an alternative to the metabolic syndrome? Results of the IMAP Study (multidisciplinary intervention in primary care). Int J Obes. 2011;35(2):292–299.
   PubMed Web of Science ®Google Scholar
• Zhao K, Yang SS, Wang HB, Chen K, Lu ZH, Mu YM. Association between the hypertriglyceridemic waist phenotype and prediabetes in Chinese adults aged 40 years and older. J Diabetes Res. 2018;2018:1031939. doi:10.1155/2018/1031939
   PubMed Web of Science ®Google Scholar
• Fernandez-Garcia JC, Munoz-Garach A, Martinez-Gonzalez MA, et al. Association between lifestyle and hypertriglyceridemic waist phenotype in the PREDIMED-plus study. Obesity. 2020;28(3):537–543. doi:10.1002/oby.22728
   Web of Science ®Google Scholar
• Xuan Y, Shen Y, Wang S, et al. The association of hypertriglyceridemic waist phenotype with hypertension: a cross-sectional study in a Chinese middle aged-old population. J Clin Hypertens. 2022;24(2):191–199. doi:10.1111/jch.14424
   Web of Science ®Google Scholar
• Chen S, Guo X, Dong S, et al. Association between the hypertriglyceridemic waist phenotype and hyperuricemia: a cross-sectional study. Clin Rheumatol. 2017;36(5):1111–1119. doi:10.1007/s10067-017-3559-z
   PubMed Web of Science ®Google Scholar
• Li Y, Zhou C, Shao X, et al. Hypertriglyceridemic waist phenotype and chronic kidney disease in a Chinese population aged 40 years and older. PLoS One. 2014;9(3):e92322. doi:10.1371/journal.pone.0092322
   PubMed Web of Science ®Google Scholar
• Zeng J, Liu M, Wu L, et al. The association of hypertriglyceridemic waist phenotype with chronic kidney disease and its sex difference: a cross-sectional study in an urban Chinese elderly population. Int J Environ Res Public Health. 2016;13(12):1233. doi:10.3390/ijerph13121233
   Web of Science ®Google Scholar
• Zhou C, Li Y, Shao X, Zou H. Identification of chronic kidney disease risk in relatively lean Southern Chinese: the hypertriglyceridemic waist phenotype vs. anthropometric indexes. Eat Weight Disord. 2018;23(6):885–892. doi:10.1007/s40519-017-0476-8
   Web of Science ®Google Scholar
• Ramezankhani A, Azizi F, Ghanbarian A, Parizadeh D, Hadaegh F. The hypertriglyceridemic waist and waist-to-height ratio phenotypes and chronic kidney disease: cross-sectional and prospective investigations. Obes Res Clin Pract. 2017;11(5):585–596. doi:10.1016/j.orcp.2016.11.003
   Web of Science ®Google Scholar
• Huang J, Zhou C, Li Y, et al. Visceral adiposity index, hypertriglyceridemic waist phenotype and chronic kidney disease in a southern Chinese population: a cross-sectional study. Int Urol Nephrol. 2015;47(8):1387–1396. doi:10.1007/s11255-015-1040-y
   Web of Science ®Google Scholar
• Wan H, Chen S, Cai Y, et al. Lead exposure and its association with cardiovascular disease and diabetic kidney disease in middle-aged and elderly diabetic patients. Int J Hyg Environ Health. 2021;231:113663. doi:10.1016/j.ijheh.2020.113663
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang W, Wang N, et al. Thyroid parameters and kidney disorder in Type 2 diabetes: results from the METAL study. J Diabetes Res. 2020;2020:4798947. doi:10.1155/2020/4798947
   PubMed Web of Science ®Google Scholar
• Wang N, Chen Y, Ning Z, et al. Exposure to famine in early life and nonalcoholic fatty liver disease in adulthood. J Clin Endocrinol Metab. 2016;101(5):2218–2225. doi:10.1210/jc.2016-1076
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen Y, Xia F, et al. A higher ratio of estradiol to testosterone is associated with autoimmune thyroid disease in males. Thyroid. 2017;27(7):960–966. doi:10.1089/thy.2016.0661
   Web of Science ®Google Scholar
• Zhou BF; Cooperative Meta-Analysis Group of the Working Group on Obesity in C. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults–study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15(1):83–96.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419. doi:10.1007/BF00280883
   PubMed Web of Science ®Google Scholar
• Ji H, Zhang H, Xiong J, et al. eGFRs from Asian-modified CKD-EPI and Chinese-modified CKD-EPI equations were associated better with hypertensive target organ damage in the community-dwelling elderly Chinese: the Northern Shanghai Study. Clin Interv Aging. 2017;12:1297–1308. doi:10.2147/CIA.S141102
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Tanaka M, Okada H, et al. Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol. 2015;10(4):578–583. doi:10.2215/CJN.08980914
   PubMed Web of Science ®Google Scholar
• Ko GT, Liu KH, So WY, et al. Cutoff values for central obesity in Chinese based on mesenteric fat thickness. Clin Nutr. 2009;28(6):679–683. doi:10.1016/j.clnu.2009.05.017
   Web of Science ®Google Scholar
• Zhu D; Society CD. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition); 2021.
   Google Scholar
• Chen S, Guo X, Yu S, Sun G, Li Z, Sun Y. Association between the hypertriglyceridemic waist phenotype, prediabetes, and diabetes mellitus in rural Chinese population: a cross-sectional study. Int J Environ Res Public Health. 2016;13(4):368. doi:10.3390/ijerph13040368
   Web of Science ®Google Scholar
• Afonso C, Sousa-Santos AR, Santos A, et al. Frailty status is related to general and abdominal obesity in older adults. Nutr Res. 2021;85:21–30. doi:10.1016/j.nutres.2020.10.009
   Web of Science ®Google Scholar
• Valencia WM, Florez H. How to prevent the microvascular complications of type 2 diabetes beyond glucose control. BMJ. 2017;356:i6505. doi:10.1136/bmj.i6505
   PubMed Web of Science ®Google Scholar
• Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Winkelmayer WC, Nally JV Jr. Diabetes control and the risks of ESRD and mortality in patients with CKD. Am J Kidney Dis. 2017;70(2):191–198. doi:10.1053/j.ajkd.2016.11.018
   PubMed Web of Science ®Google Scholar
• Afkarian M, Sachs MC, Kestenbaum B, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. 2013;24(2):302–308. doi:10.1681/ASN.2012070718
   PubMed Web of Science ®Google Scholar
• Du P, Zhang B, Wang HJ, et al. The prevalence and secular trends of abdominal obesity among Chinese adults, 1993–2011. Ann Epidemiol. 2015;25(10):797–799. doi:10.1016/j.annepidem.2015.06.082
   Web of Science ®Google Scholar
• Qiu Y, Zhao Q, Wang N, et al. Association of hypertriglyceridemic waist phenotype with renal function impairment: a cross-sectional study in a population of Chinese adults. Nutr Metab. 2020;17:63. doi:10.1186/s12986-020-00483-7
   Google Scholar
• Su W, Wang J, Mu Y. Association between hypertriglyceridemic waist phenotype and increased urinary albumin-creatinine ratio in Chinese adults: the REACTION Study. Diabetes Metab Syndr Obes. 2020;13:2965–2974. doi:10.2147/DMSO.S257736
   PubMed Web of Science ®Google Scholar
• Chen D, Sun H, Lu C, Chen W, Guo VY. The association between hypertriglyceridemic-waist phenotype and chronic kidney disease: a cohort study and meta-analysis. Sci Rep. 2022;12(1):1935. doi:10.1038/s41598-022-05806-7
   Web of Science ®Google Scholar
• Cunha de Oliveira C, Carneiro Roriz AK, Eickemberg M, Barreto Medeiros JM, Barbosa Ramos L. Hypertriglyceridemic waist phenotype: association with metabolic disorders and visceral fat in adults. Nutr Hosp. 2014;30(1):25–31. doi:10.3305/nh.2014.30.1.7411
   Web of Science ®Google Scholar
• Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis. 2005;45(2):275–280. doi:10.1053/j.ajkd.2004.09.034
   PubMed Web of Science ®Google Scholar
• Koppe L, Pelletier CC, Alix PM, et al. Insulin resistance in chronic kidney disease: new lessons from experimental models. Nephrol Dial Transpl. 2014;29(9):1666–1674. doi:10.1093/ndt/gft435
   Web of Science ®Google Scholar
• Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39–48. doi:10.1161/CIRCULATIONAHA.106.675355
   PubMed Web of Science ®Google Scholar
• Zhang X, Lerman LO. The metabolic syndrome and chronic kidney disease. Transl Res. 2017;183:14–25. doi:10.1016/j.trsl.2016.12.004
   Web of Science ®Google Scholar
• Mende C, Einhorn D. Fatty kidney disease: the importance of ectopic fat deposition and the potential value of imaging. J Diabetes. 2022;14(1):73–78. doi:10.1111/1753-0407.13232
   Web of Science ®Google Scholar
• Rickards E. Remarks on the fatty transformation of the kidney. Br Med J. 1883;2(1175):2–3. doi:10.1136/bmj.2.1175.2
   Google Scholar
• Hall J, Juncos L, Wang Z, Hall M, Do Carmo J, da Silva A. Obesity, hypertension, and chronic kidney disease. Int J Nephrol Renovasc Dis. 2014;7:75–88. doi:10.2147/IJNRD.S39739
   PubMedGoogle Scholar
• Liu PJ, Lou HP, Zhu YN. Screening for metabolic syndrome using an integrated continuous index consisting of waist circumference and triglyceride: a Preliminary Cross-sectional Study. Diabetes Metab Syndr Obes. 2020;13:2899–2907. doi:10.2147/DMSO.S259770
   PubMed Web of Science ®Google Scholar
• Zhou M, Li F, Tang H, et al. The hypertriglyceridemic waist phenotype is associated with fatty liver and glycometabolic profiles in overweight and obese adults: a cross-sectional study. Sci Rep. 2022;12(1):2410. doi:10.1038/s41598-021-00825-2
   Web of Science ®Google Scholar
• Anders HJ, Huber TB, Isermann B, Schiffer M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol. 2018;14(6):361–377. doi:10.1038/s41581-018-0001-y
   PubMed Web of Science ®Google Scholar